Tag Archives: stocks

Making CNS Pay Off

In preparing the October issue of NeuroPerspective, we noted that September was another solid month for the neuroscience stock sector, with a number of companies showing dramatic valuation gains. In fact, the index was up over 11% in just the … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , | Leave a comment